Understood
This website is using cookies. More details

BioMedomics COVID-19 IgM/IgG Rapid test

BioMedomics has developed and launched one of the world’s first rapid point-of-care lateral flow immunoassays for the diagnosis of coronavirus infection...

OXFORD BIOSYSTEMS and BIOMEDOMICS™ sign exclusive distribution agreement for UK

Founded in 2007, BioMedomics is a privately-held clinical diagnostics company in North Carolina, USA. Their researchers combine biology, biochemistry and...

Oxford Biosystems

115J Olympic Avenue

Milton Park

Oxfordshire

OX14 4SA

Oxford Biosystems has pledged to be an Antibiotic Guardian

Members of:

BIVDA Member 2019 IBMS member